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Abstract
Background: Cocoa, coffee, green tea and garcinia contain large amounts of polyphenols. Polyphenols are well-
known phytochemicals and found in plants, and have modulated physiological and molecular pathways that are
involved in energy metabolism, adiposity, and obesity.
Methods: To evaluate the obesity-lowering effect of a combined extract (comprising cocoa, coffee, green tea and
garcinia; CCGG) in high-energy diet (HED)-induced obese rats. Male Sprague Dawley rats (8 weeks old) were
randomly divided into four groups (n = 12 per group): normal diet with vehicle treatment (Control), and HED to
receive vehicle or CCGG by oral gavage at 129, 258, or 517 mg/kg/day for 4 weeks, designated the HED, 0.5X, 1X
and 1X groups, respectively.
Results: HED induced macrovesicular fat in the liver and the formation of adipose tissues, and significantly
increased the levels of serum free fatty acids (FFA), triacylglycerol (TG), total cholesterol (TC), low density lipoprotein
cholesterol (LDL-C), and LDL-C/HDL-C, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and ketone
bodies in serum, and hepatic TG and TC levels, and decreased the levels of high density lipoprotein cholesterol
(HDL-C) in serum and lipase activity in fat tissues. Treatment with CCGG could significantly decrease the levels of
FFA, TG, TC, LDL-C, and LDL-C/HDL-C, AST, ALT, and ketone bodies in serum, and hepatic TG and TC contents, and
increase the levels of HDL-C in serum and lipase activity in fat tissues compared to the HED group. Liver
histopathology also showed that CCGG could significantly reduce the incidence of liver lesions.
Conclusion: These results suggested that CCGG stimulated lipid metabolism in HED-induced obese rats, which is
attributable to fat mobilization from adipose tissue.
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Background
Obesity is a serious medical health problem in the
world, and was estimated over 500 million adults in
2008 according to the World Health Organization [1].
Obesity, which is an imbalance between energy intake
and expenditure, is associated with increased health-care
costs, reduced quality of life, and increased risk of various
chronic diseases such as heart and cardiovascular disease,
type 2 diabetes, hypertension, hypercholesterolemia, and
various forms of cancer [2–4]. Genetic, physiological,
psychological and gut microbial factors are responsible
for the significant increase in prevalence of obesity and
its sequels [5–7]. Currently, the available therapeutic
approaches for treating obesity have a number of side
effects. Therefore, it is an increasing interesting in natural
products as anti-obesity agents [8, 9].
Recently, natural bioactive phytochemicals present in
natural products have been discovered for their potential
health benefit effects on the prevention of chronic disor-
ders such as cancer, cardiovascular disease, inflammatory
and metabolic diseases including obesity and insulin
resistance. Polyphenols, a class of naturally-occurring
phytochemicals, have been shown to modulate physio-
logical and molecular pathways that are involved in energy
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metabolism, adiposity, and obesity [10]. In cell cultures
and animal models of obesity, and in some human clinical
and epidemiological studies have demonstrated that
polyphenols have beneficial effects on adiposity and
obesity as complementary agents in the up-regulation
of energy expenditure [10].
Cocoa, coffee, green tea and garcinia (CCGG) all con-
tain large amounts of polyphenols including proantho-
cyanidins, chlorogenic acids, catechins, and xanthones
[11–14]. Among them, there were strong evidences that
dyslipidaemia mediated by cocoa, coffee, green tea and
garcinia; insulin resistance mediated by cocoa, coffee,
and garcinia; inflammation mediated by cocoa, coffee,
green tea and garcinia [15–19]. Recently, we demon-
strated that a 6-week treatment of CCGG supplementa-
tion significantly reduced serum lipid content (TC, TG,
and LDL-C) and hepatic lipid content (TC and TG) in
high cholesterol diet induced hamsters, and speculated
this was attributable to the intake of polyphenols. Such a
TG-lowering effect was of interest to us because TG
accumulation in liver is one of the major causes of fatty
liver diseases [20]. To evaluate the TG-lowering effect of
dietary CCGG in obese rats, we fed animals with a moder-
ately high energy diet containing 8 % soybean oil and 44 %
sweetened condensed milk and supplemented with three
different dose of CCGG for 4 weeks.
Methods
Materials
A commercially available supplement consisting of
CCGG (beans of Theobroma cacao, beans of Coffea
robusta, leaves of Camellia sinensis and fruits of Garcinia
mangostana) was provided by Sunrider International (CA,
USA) and employed as dietary treatment. The CCGG
contained 5.2 kcal/g with 30‰ (wt/wt) as protein, 290 ‰
(wt/wt) as total fat, 4 ‰ (wt/wt) as saturated fat, 0 ‰
(wt/wt) as trans fat, 610 ‰ (wt/wt) as carbohydrate,
0.05 ‰ (wt/wt) as sodium, 50 ‰ (wt/wt) as dietary
fiber, 0.003 ‰ (wt/wt) as iron, and 0.02 ‰ (wt/wt) as
calcium. In addition, the total polyphenol and EGCG in
CCGG were 196 mg/g and 4.0 mg/g, respectively. The
supplement was stored at room temperature and kept
in the dark and dry cabinet. The treatment was freshly
prepared for daily administration.
Animals and treatment
Male Sprague Dawley rats (8 weeks old) with specific
pathogen-free conditions were purchased from BioLASCO
(A Charles River Licensee Corp., Yi-Lan, Taiwan). The ex-
perimental design was depicted as in the Fig. 1. The experi-
mental animals were given 2 weeks to acclimatize to the
environment and diet. All animals were fed a chow diet
(No. 5001; PMI Nutrition International, Brentwood,
MO, USA) and distilled water ad libitum, and maintained
at a regular cycle (12-h light/dark) at room temperature
(23 ± 2 °C) and 50 ~ 60 % humidity. The bedding was
changed and cleaned twice per week. All animal experi-
mental protocols were approved by the Institutional
Animal Care and Use Committee (IACUC) of National
Taiwan Sport University, and the study conformed to the
guidelines of the protocol IACUC-10312 approved by the
IACUC ethics committee.
All animals were randomly assigned to five groups
(12 rats/group). The dose of CCGG for humans is 2.5 g
Fig. 1 Experimental design. After 2-week adaption, 60 rats were divided randomly into five groups: the normal group was fed a standard chow
diet (control, n = 12) and the experimental group with a high-energy diet (HED, n = 48). The 48 obese rats were divided into four groups
(n = 12/each group): 1) HED with sedentary control (HED), 2) HED with 129 mg/kg rat/day CCGG (CCGG −0.5X), 3) HED with 258 mg/kg
rat/day CCGG (CCGG -1X) and, 4) HED with 517 mg/kg rat/day CCGG (CCGG -2X)
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per day. The rat dose (258 mg/kg) was converted from a
human equivalent dose (HED) based on body surface area
by the following formula from the US Food and Drug Ad-
ministration: assuming a human weight of 60 kg, the HED
for 2500 (mg)/60 (kg) = 41.67 × 6.2 = 258 mg/kg; the con-
version coefficient 6.2 was used to account for differences
in body surface area between rat and human. Therefore,
the CCGG-0.5X and CCGG-2X would be 129 mg/kg and
517 mg/kg rat/day, respectively. CCGG was dissolved in
distilled water. The vehicle control and HED groups was
performed with the same volume of distilled water or
CCGG solution, respectively, equivalent to body weight.
The food intake was monitored daily, and BW was re-
corded weekly. The feed efficiency was calculated as
weight gain/food intake × 100 %.
HED composition
Rats were fed a standard chow diet or a HED as de-
scribed in our previous study [21]. The standard chow
(No. 5001) contained 3.35 kcal/g with 28.5 % as protein,
13.4 % as fat, and 58.1 % as carbohydrates. The HED
contained 8 % (wt/wt) soybean oil, 44 % (wt/wt) sweet-
ened condensed milk (Original, Eagle Brand, Nestle) and
48 % (wt/wt) standard chow, for 3.76 kcal/g with 15.5 %
as protein, 33.4 % as fat and 51.1 % as carbohydrates.
Biochemical analysis of serum samples
At the end of experiment, all rats were killed by 95 %
CO2 asphyxiation, and blood was immediately collected.
The serum was prepared by centrifugation at 1500 × g,
4 °C for 15 min. Serum free fatty acids (FFA) were mea-
sured by use of Siemens Advia 1800 analyzer (Siemens
Healthcare Diagnostics, IL, USA). Serum total cholesterol
(TC), low density lipoprotein cholesterol (LDL-C), high
density lipoprotein cholesterol (HDL-C) levels were deter-
mining by use of Hitachi C1600 analyzer (Hitachi C1600,
Hitachi, Japan). The concentrations of serum triacylglyc-
erol (TG), glucose, aspartate transaminase (AST), alanine
transaminase (ALT), uric acid (UA), creatinine (CREA),
blood urea nitrogen (BUN), ketone bodies, sodium (Na),
and potassium (K) were analyzed using Beckman DX 800
(Beckman Coulter, Inc., Fullerton, CA).
Liver lipid content
After blood collection, liver tissues were excised from
rats. To determine liver cholesterol and triglycerides,
20 mg of liver tissue was homogenized in a 200 μL
solvent (chloroform : isopropanol : NP40 = 7 : 11 : 0.1).
Centrifuged at 12 000 × g for 10 min, an aliquot of 100 μL
was extracted and dried. The pellet was reconstituted with
a buffer (1 M of potassium phosphate, pH = 7.4, 500 mM
of sodium chloride, 50 mM of cholic acid), and water
bath sonication was employed to dissolve the precipitate.
A cholesterol fluorometric assay kit (Cayman, Ann Arbor,
MI, USA) and triglyceride colorimetric assay kit (Cayman,
Ann Arbor, MI, USA) were used to analyze liver choles-
terol and triglyceride contents.
Lipase activity of epididymal fat pad
The epididymal fat pad (EFP) was excised from rats. To
determine lipase activity, 100 mg of EFP was homoge-
nized, centrifuged at 12 000 × g for 10 min. and the
supernatant was measured using the Bioviaion kit
(Biovision, Milpitas, CA, USA) in accordance with the
manufacturer’s specifications.
Histological staining of tissues
Liver, fat, kidney, and heart tissues were collected and
immediately fixed in 10 % formalin after being weighed.
Tissue was then embedded in paraffin and cut into 4-
μm thick slices, then stained with hematoxylin and eosin
(H&E) and examined under a light microscope equipped
with a CCD camera (BX-51, Olympus, Tokyo) by a
clinical pathologist.
Statistical analysis
All data were expressed as mean ± SD. Statistical differ-
ences were analyzed by one-way ANOVA with Duncan’s
test. Mann–Whitney U-test was only used for data
comparisons of ketone bodies. P < 0.05 was considered
statistically significant.
Results
Effects of CCGG supplementation on body weight, diet
intake, and food efficiency
The effects of CCGG supplementation on final body
weight, diet intake, and food efficiency in HED-fed rats
were shown in Table 1. The initial body weight for con-
trol and HED rats were similar. Rats fed on the normal
diet and HED continued to show increased body weight
(Fig. 2) and food intake until the end of the study. After
4-week induced obesity, the body weight was higher for
HED than control rats (P < 0.05). After CCGG treatment
in the HED rats, the body weight significantly decreased
in CCGG-1X and CCGG-2X groups compared to HED
group (P < 0.05). The average final body weight of
CCGG-0.5X, CCGG-1X, and CCGG-2X groups de-
creased by 2.0, 5.0, and 8.9 % compared with HED
group. In addition, the HED groups with or without
treatment of CCGG did not cause diarrhea during the
experiment. Treatment with HED, CCGG-0.5X, CCGG-
1X, and CCGG-2X slightly reduced the daily food intake
compared to vehicle group, which is due to HED had
higher energy intake than the normal diet. Food effi-
ciency was increased in the HED group compared with
the vehicle group, but treatment of CCGG-0.5X, CCGG-
1X, and CCGG-2Xsignificantl reduced that value in the
HED group groups.
Huang et al. BMC Complementary and Alternative Medicine  (2016) 16:100 Page 3 of 10
Effects of CCGG supplementation on fat pads
Fat tissue weights at the end of the study were shown in
Table 2. The epididymal fat pad (EFP), renal fat pad
(RFP), mesenteric fat pad (MFP) are white adipose tis-
sues in the body. EFP, RFP, and MFP mass was greater
for HED-alone than control rats, and CCGG-0.5X,
CCGG-1X, and CCGG-2X groups decreased the mass.
The relative weight of EFP, RFP and MFP was higher for
HED-alone than control rats by 65.5 % (P = 0.0092),
354.4 % (P < 0.0001), and 103.5 % (P < 0.0001), respect-
ively. However, CCGG-0.5X, CCGG-1X, and CCGG-2X
groups could decrease the relative weight as compared
with HED alone, by 6.4, 5.9 or 18.2 % (P = 0.0277), 59.3 %
(P < 0.0001), 56.0 % (P < 0.0001), or 65.3 % (P < 0.0001)
and 11.6, 12.7, or 19.7 % (P = 0.0035), respectively. The
body fat percentage of control, HED, CCGG-0.5X,
CCGG-1X, and CCGG-2X groups were 2.31 ± 0.37,
5.10 ± 0.92, 3.89 ± 0.78, 3.92 ± 1.07, 3.44 ± 0.74 %, respect-
ively. In addition, CCGG dose-dependently decreased the
relative weight of MFP. The body fat percentage of the
HED rats was dramatically elevated 120.8 % compared to
vehicle rats (P < 0.0001). After the CCGG-0.5X, CCGG-1X,
and CCGG-2X supplementation were markedly decreased
23.7 % (P = 0.0006), 23.1 % (P = 0.0008), and 32.5 %
(P < 0.0001) compared to the HED rats without treatment.
Recent studies showed that feeding rats with a high-fat
diet induced the changes in several enzymatic reactions
related to carbohydrate metabolism in liver and adipose
tissue [22, 23]. Thus, it supported the possibility that
CCGG may have an alternation on several enzymatic reac-
tions and reduce the formation of adipose tissue.
Effects of CCGG supplementation on serum biochemical
parameters associated with lipid profiles
Effects of CCGG supplementation on FFA, TG, TC,
LDL-C, HDL-C, and LDL-C/HDL-C were shown in Fig. 3.
An HED diet fed to the SD rats significantly increased the
serum levels of FFA, TG, TC, LDL-C, and LDL-C/HDL-C
by 28.6 % (P < 0.0001), 82.5 % (P < 0.0001), 44.2 %
(P < 0.0001), 70.2 % (P < 0.0001), and 146.0 % (P < 0.0001),
respectively, and decreased the serum level of HDL-C by
27.0 % (P < 0.0001) compared to those in the vehicle
group) (Table 3). After the CCGG supplementation, the
treated groups exhibited a significant decrease in the serum
levels of FFA (12.9, 15.2, and 25.2 % reduction in the
CCGG-0.5X, CCGG-1X, and CCGG-2X groups, respect-
ively), TG (30.7, 40.3, and 42.5 % reduction in the CCGG-
0.5X, CCGG-1X, and CCGG-2X groups, respectively), TC
(18.0, 22.4, and 25.7 % reduction in the CCGG-0.5X,
CCGG-1X, and CCGG-2X groups, respectively), LDL-C
(30.5, 30.7, and 32.8 % reduction in the CCGG-0.5X,
CCGG-1X, and CCGG-2X groups, respectively), HDL-C
(22.9, 25.7, and 35.9 % increase in the CCGG-0.5X,
CCGG-1X, and CCGG-2X groups, respectively), and LDL-
C/HDL-C ratio (44.6, 46.1, and 50.7 % reduction in the
CCGG-0.5X, CCGG-1X, and CCGG-2X groups, respect-
ively), compared with the HED group. Strongly dose
dependent effects were observed in the serum levels of
FFA, TG, TC, HDL-C, and LDL-C/HDL-C.
Effect of CCGG supplementation on hepatic triglycerides
and total cholesterol
The effects of CCGG supplementation on hepatic TG and
TC in HED-fed rats were shown in Fig. 4. An HED diet
fed to rats markedly accumulated hepatic TG (a 12.5-fold
increase compared with vehicle group, P < 0.0001) and
hepatic TC (a 2.5-fold increase compared with vehicle
group, P < 0.0001). In the liver tissues, CCGG-0.5X,
Fig. 2 Body weights over the course of 4 weeks. Control; vehicle
control, HED; high-energy diet control, 0.5X; HED with 129 mg/kg/d
of CCGG, 1X; HED with 258 mg/kg/d of CCGG, 2X; HED with
517 mg/kg/d of CCGG. Data are mean ± SD (n = 12 rats/group).
Values with different letters (a, b, c, d) differ significantly at P <
0.05 by one-way ANOVA
Table 1 The effects of CCGG supplementation on final body weight, diet intake, and food efficiency in HED-fed rats
Control HED 0.5X 1X 2X
Initial BW (g) 364 ± 18 366 ± 6 365 ± 8 363 ± 8 363 ± 15
Final BW (g) 484 ± 27a 563 ± 25d 553 ± 20cd 538 ± 36c 512 ± 21b
Diet intake (g/rat/day) 15.9 ± 0.3c 15.4 ± 0.3b 15.2 ± 0.5b 15.3 ± 0.5b 14.1 ± 0.3a
Feed efficiency (%) 26.9 ± 3.1a 45.8 ± 4.2d 44.1 ± 3.2cd 41.1 ± 6.9bc 37.7 ± 3.0b
Control, vehicle control; HED, high-energy diet control; 0.5X, HED with 129 mg/kg/d of CCGG; 1X, HED with 258 mg/kg/d of CCGG; 2X, HED with 517 mg/kg/d of
CCGG. Data are mean ± SD (n = 12 rats/group). Values with different letters (a, b, c, d) differ significantly at P < 0.05 by one-way ANOVA
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Table 2 The effects of CCGG supplementation on the mass of epididymal fat pad (EFP), renal fat pad (RFP), mesenteric fat pad
(MFP), and total body fat in HED-fed rats
Control HED 0.5X 1X 2X
EFP (g) 5.24 ± 1.33a 10.06 ± 1.94c 9.23 ± 2.13bc 9.05 ± 3.01bc 7.51 ± 2.02b
RFP (g) 1.53 ± 0.48a 8.09 ± 2.87c 3.24 ± 0.91b 3.43 ± 1.90b 2.54 ± 0.78ab
MFP (g) 3.93 ± 0.69a 9.33 ± 1.54c 8.05 ± 1.91bc 7.76 ± 2.16b 6.79 ± 1.66b
Total body fat (g) 10.7 ± 2.2a 27.5 ± 5.8c 20.5 ± 4.3b 20.2 ± 6.9b 16.8 ± 4.0b
Relative EFP (%) 1.13 ± 0.23a 1.87 ± 1.30c 1.75 ± 0.39bc 1.76 ± 0.47bc 1.53 ± 0.39b
Relative RFP (%) 0.33 ± 0.10a 1.50 ± 0.49c 0.61 ± 0.17b 0.66 ± 0.32b 0.52 ± 0.15ab
Relative MFP (%) 0.85 ± 0.11a 1.73 ± 0.24c 1.53 ± 0.35bc 1.51 ± 0.32bc 1.39 ± 0.31b
Body fat percentage (%) 2.31 ± 0.37a 5.10 ± 0.92c 3.89 ± 0.78b 3.92 ± 1.07b 3.44 ± 0.74b
Control, vehicle control; HED, high-energy diet control; 0.5X, HED with 129 mg/kg/d of CCGG; 1X, HED with 258 mg/kg/d of CCGG; 2X, HED with 517 mg/kg/d of
CCGG. Data are mean ± SD (n = 12 rats/group). Values with different letters (a, b, c) differ significantly at P < 0.05 by one-way ANOVA
Fig. 3 Effects of CCGG supplementation on serum lipids. a serum total cholesterol levels. b serum triglycerides levels. c serum high-density
lipoprotein cholesterol. d serum low-density lipoprotein cholesterol. e serum low-density lipoprotein cholesterol. Control; vehicle control, HED;
high-energy diet control, 0.5X; HED with 129 mg/kg/d of CCGG, 1X; HED with 258 mg/kg/d of CCGG, 2X; HED with 517 mg/kg/d of CCGG. Data
are mean ± SD (n = 12 rats/group). Values with different letters (a, b, c) differ significantly at P < 0.05 by one-way ANOVA
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CCGG-1X, and CCGG-2X reduced TG (154 ± 74, 147 ±
69, and 95 ± 50 mg/g, respectively) and TC (0.37 ± 0.11,
0.31 ± 0.10, and 0.27 ± 0.07 mg/g) levels compared with
the levels of TG and TC (248 ± 78 and 0.49 ± 0.15 mg/g,
respectively) in the HED group. Thus, treating HED rats
with CCGG-0.5X, CCGG-1X, or CCGG-2X significantly
reduced hepatic TG and TC (37.9, 40.7, or 61.6 % and
24.1, 36.8, or 45.0 %, respectively) compared with those in
vehicle group. These results supposed that CCGG may
have an inhibitory action on cholesterol synthesis in liver,
a facilitating effect on biliary excretion of TG.
Effect of CCGG supplementation on serum biochemical
parameters associated with liver function
AST and ALT have long been considered effective indica-
tors of hepatic injury. Effect of CCGG supplementation
on serum AST and ALT levels were shown in Fig. 5. The
serum AST and ALT levels of the HED rats were dramat-
ically elevated (P < 0.0001) to 80 ± 11 and 33 ± 9 U/L,
respectively, compared to those of rats in the vehicle
group, which were 63 ± 10 and 20 ± 3 U/L, respectively.
The HED rats treated with CCGG-0.5X, CCGG-1X, or
CCGG-2X exhibited significantly lower levels of serum
AST and ALT (67 ± 9, 64 ± 8, or 58 ± 7 and 23 ± 4, 21 ± 2,
or 22 ± 3 U/L, respectively), compared with the HED
group (P < 0.0001).
Effect of CCGG supplementation on serum biochemical
parameters
Effect of CCGG supplementation on serum biochemical
parameters were shown in Table 3. As indicators of
nephrotoxicity, UA, CREA, and BUN showed no differ-
ences among all groups (P > 0.05). In addition, it appeared
that all groups have no different serum electrolyte levels
including sodium (Na+) and potassium (K+) (P > 0.05).
Thus, CCGG did not cause toxicology during the experi-
ment. Glucose also showed no differences among all
groups (P > 0.05). Chang et al. [24] showed that a high-fat
diet slightly increased glucose level compared to the ve-
hicle group, but the difference was not statistically signifi-
cant. Our result was a similar to their report. On the other
hand, an HED diet fed to the SD rats produced the ketone
Table 3 The effects of CCGG supplementation on serum biochemical parameters in HED-fed rats
Control HED 0.5X 1X 2X
TG (mg/dL) 40 ± 9a 73 ± 24b 46 ± 12a 44 ± 8a 42 ± 8a
FFA (mmol/L) 1.05 ± 0.14ab 1.35 ± 0.06d 1.18 ± 0.11c 1.15 ± 0.12bc 1.01 ± 0.15a
TC (mg/dL) 43 ± 8a 62 ± 10c 51 ± 7b 48 ± 8ab 46 ± 7ab
LDL-C (mg/dL) 4.7 ± 0.7a 8.0 ± 1.1b 5.5 ± 1.0a 5.5 ± 1.1a 5.4 ± 1.4a
HDL-C (mg/dL) 7.4 ± 0.9c 5.4 ± 1.1a 6.6 ± 0.8b 6.7 ± 0.7bc 7.3 ± 1.3bc
LDL-C/HDL-C 0.63 ± 0.11a 1.55 ± 0.37c 0.86 ± 0.21b 0.83 ± 0.20ab 0.76 ± 0.26ab
UA (mg/dL) 1.04 ± 0.22a 1.08 ± 0.18a 1.03 ± 0.20a 1.03 ± 0.17a 0.98 ± 0.23a
CREA (mg/dL) 0.39 ± 0.03a 0.40 ± 0.05a 0.39 ± 0.03a 0.39 ± 0.05a 0.38 ± 0.05a
BUN (mg/dL) 8.20 ± 0.75a 8.68 ± 1.26a 8.08 ± 1.50a 8.00 ± 0.93a 8.03 ± 1.23a
Na (mmol/L) 141 ± 2a 140 ± 1a 141 ± 1a 141 ± 2a 141 ± 1a
K (mmol/L) 4.3 ± 0.3a 4.2 ± 0.3a 4.3 ± 0.3a 4.3 ± 0.2a 4.2 ± 0.4a
Ketone bodies 0/12 12/12* 8/12*,† 3/12† 1/12†
Control, vehicle control; HED, high-energy diet control; 0.5X, HED with 129 mg/kg/d of CCGG; 1X, HED with 258 mg/kg/d of CCGG; 2X, HED with 517 mg/kg/d of
CCGG. Data are mean ± SD (n = 12 rats/group). Values with different letters (a, b, c) differ significantly at P < 0.05 by one-way ANOVA. Ketone bodies = the rats of
the positive ketone bodies/the total rats. *, P < 0.05 compared with control group, and †, P < 0.05 compared with HED group by Mann–Whitney U-test
Fig. 4 Effects of CCGG supplementation on hepatic lipids. a; hepatic total cholesterol levels. b; hepatic triglycerides levels. Control; vehicle control,
HED; high-energy diet control, 0.5X; HED with 129 mg/kg/d of CCGG, 1X; HED with 258 mg/kg/d of CCGG, 2X; HED with 517 mg/kg/d of CCGG.
Data are mean ± SD (n = 12 rats/group). Values with different letters (a, b, c, d) differ significantly at P < 0.05 by one-way ANOVA
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bodies (100 %; 12/12) compared with vehicle rats
(0 %; 0/12) (P < 0.05), which may be due to ketone bodies
are produced by the liver from fatty acids. Treatment with
CCGG-0.5X (67 %; 8/12), CCGG-1X (25 %; 3/12), or
CCGG-2X (8 %; 1/12) significantly decreased the ketone
bodies compared with the HED group (P < 0.05).
Effect of CCGG supplementation on lipase activity
The lipoprotein lipase (LPL) activity of control, HED,
CCGG-0.5X, CCGG-1X, and CCGG-2X groups were
1.09 ± 0.43, 0.28 ± 0.13, 0.50 ± 0.20, 0.57 ± 0.14, 0.61 ±
0.17 mU/mL, respectively. LPL activity of the HED rats
was dramatically decreased 74.4 % compared to vehicle
rats (P < 0.0001). After the CCGG-0.5X, CCGG-1X, and
CCGG-2X supplementation were markedly elevated 1.78-
(P = 0.0298), 2.05- (P = 0.0040), and 2.20-fold (P = 0.0012)
compared to the HED rats without treatment. It is well
known that the LPL is important in the metabolism of
lipoproteins and also in the regulation of plasma HDL
levels [25–31]. Numerous studies showed that subjects
with high plasma LPL activity have high HDL levels
[25–27], and these results were a similar to this study that
CCGG-0.5X, CCGG-1X, and CCGG-2X supplementation
with high serum LPL activity have high HDL levels.
Effect of CCGG supplementation on hepatomegaly
Rats fed with high-fat diet for 4 weeks developed a
higher degree of lipid deposition of liver tissues. Livers
of the HED rats were grossly larger compared with those
in the vehicle group and were pale in color, and their
adipose tissues were also markedly increased. This
higher fatty content (Fig. 4b) was confirmed by H & E
staining of the liver sections, and severe cytoplasmic
vacuoles in the hepatocytes were observed in the HED
group, whereas the histology appeared normal in the ve-
hicle group (Fig. 6). The fatty liver was represented as
mixed (macro- and microvesicular) lipid droplets in the
HED group. Feeding with HED also resulted in a more
prominent inflammation and necrosis which was corrob-
orated by morphological analysis of the abundance of in-
flammatory cells and pericentral necrosis. In addition,
livers of the HED group showed widespread deposition
of lipid droplets of different sizes inside the parenchymal
cells (arrow position, Fig. 6). In contrast, livers from the
vehicle group showed scattered, negligible droplets of fat
which were not visibly. Treatment with CCGG-0.5X,
CCGG-1X, and CCGG-2X reduced hepatomegaly and
the formation of fatty liver and fat in these rats. These
results indicate that treating HED rats for 4 weeks with
CCGG-0.5X, CCGG-1X, and CCGG-2X decreased the
accumulation of macrovesicular fat in the liver and the
formation of adipose tissues. In addition, H&E staining
of the kidneys and hearts revealed showed no differences
among all groups (data not shown).
Discussion
Obesity causes the accumulation of excess TG in adipose
tissue and leads to adverse health problems, including
heart disease, cerebrovascular disease, diabetes, hyperten-
sion, hypercholesterolemia and other chronic diseases. [1].
Although the etiology of obesity is complex, dietary fac-
tors, particularly the consumption of HED, is considered a
risk factor for its development. The numerous studies in-
dicated that consumption of HED leads to obesity and
then rats fed HED weighed more than normal diet rats
and they developed substantially more adipose tissue than
normal rats and acquired the hyperlipidemia effects typic-
ally associated with obesity [32]. The HED-induced rat
has been widely used as a model for the evaluation of
hyperlipidemic prevention and has many similarities be-
tween the metabolism diseases observed in HED-induced
rats and in humans. The purpose of this study was to
systematically investigate the effects of CCGG on HED-
induced obesity in rats.
Cocoa, coffee, green tea and garcinia (CCGG) contain
abundant polyphenols, particularly proanthocyanidins,
chlorogenic acids, catechins and xanthones, respectively
[11–14]. In recent years, there has been increasing inter-
est in polyphenols from a wide variety of traditional
herbal for against blood lipids and related inflammatory
responses plants [33–36]. Xu et al. [37] revealed that
polysaccharides markedly reduced the leptin expressions
Fig. 5 Effects of CCGG supplementation on liver function. a; aspartate aminotransferase. b; alanine aminotransferase. Control; vehicle control, HED;
high-energy diet control, 0.5X; HED with 129 mg/kg/d of CCGG, 1X; HED with 258 mg/kg/d of CCGG, 2X; HED with 517 mg/kg/d of CCGG. Data
are mean ± SD (n = 12 rats/group). Values with different letters (a, b, c) differ significantly at P < 0.05 by one-way ANOVA
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in white adipose tissue, and serum leptin levels in obese
patients were significantly higher than the normal group.
In this study, cumulative food intake over the experi-
mental period was similar in both groups. Rats fed with
high-fat diet for 4 weeks markedly increased body
weight compared to normal diet group. This showed
that the HED group had higher energy intake compared
to the normal diet group, and the HED contributed to
migration of obesity. These results were a similar to
these studies [38–40]. Parallel to the change of body
weight, the weights of white adipose tissues (EFP, RFP,
and MFP) were higher in the HED group than in the
normal diet group. Treating HED rats with CCGG-0.5X,
CCGG-1X, and CCGG-2X for 4 weeks significantly re-
duced body weight gain, and the attenuated body weight
of the treated animals may be due to the presence of a
decreased amount of fatty tissue and a decreased adipo-
cyte size. The histological appearance and size of white
adipocytes in HED groups were drastically larger than
the vehicle group but those of CCGG-0.5X, CCGG-1X,
and CCGG-2X groups were quite smaller than HED
alone group. In addition, HED diet fed to the SD rats
significantly increased the serum levels of FFA, TG, TC,
LDL-C, LDL-C/HDL-C AST and ALT, and decreased
the serum level of HDL-C compared to those in the ve-
hicle group. After the CCGG supplementation, the treated
groups exhibited a significant reduction in the serum
levels of FFA, TG, TC, LDL-C, LDL-C/HDL-C AST and
ALT, and increasing in the serum level of HDL-C com-
pared to those in the vehicle group. Shepherd and Kahn
[41] showed that obese and diabetic patients increased
plasma FFA levels, which is due to abnormal release by
insulin-resistant adipocytes. With insulin resistance, the
combination of elevated plasma concentrations of fatty
acids promotes hepatic fatty acid synthesis and impairs β-
oxidation, which further leads to hepatic steatosis [42].
Thus, treatment with CCGG-0.5X, CCGG-1X, or CCGG-
2X may decrease hepatic fatty acid synthesis recovery β-
oxidation, which further reduced hepatic steatosis.
CCGG contains cocoa, coffee, green tea and garcinia.
Nwichi et al. [16] reported that an 8-weeks administration
of cocoa extract significantly reduced hyperlipidaemia in
cholesterol-fed rats. Gu et al. [15] found that 8 % unsweet-
ened cocoa powder (approximately equivalent to 465 mg/
kg/d in human) for 10-weeks significantly ameliorated
obesity-related inflammation, insulin resistance, and fatty
Fig. 6 Histopathology of liver tissues. (H & E stain, magnification: 200×, Scale bar: 40 μm). Control; vehicle control, HED; high-energy diet control,
0.5X; HED with 129 mg/kg/d of CCGG, 1X; HED with 258 mg/kg/d of CCGG, 2X; HED with 517 mg/kg/d of CCGG
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liver disease. Song et al. [17] found that that an 11-weeks
administration of 0.3 % and 0.9 % decaffeinated green cof-
fee bean significantly reduced high-fat-diet induced body
weight gain and increments in plasma lipids, glucose, and
insulin levels. Panchal et al. [43] showed that 5 % (ap-
proximately equivalent to 294 mg/kg/d in human) aque-
ous extract of coffee for 8 weeks significantly attenuated
hypertension and impairment in glucose homeostasis
without affecting abdominal fat deposition and plasma
lipid profile on a rat model of human metabolic syndrome.
Xu et al. [37] demonstrated that 400 or 800 mg/kg/d
green tea polysaccharides and polyphenols treated with
high-fat diet fed rats for 6 weeks significantly reduce
serum lipids. Luo et al. [18] demonstrated that supple-
mentation with 1.0 or 2.0 g/kg body weight (approxi-
mately equivalent to 161 or 323 mg/kg/d in human) green
tea leaf powder for 30 days resulted in a significant
decrease in plasma TC levels and circulating immune
complexes and an increase in HDL-C. Dulloo et al. [44]
also found that administration of a green tea extract sig-
nificantly increased energy expenditure and fat oxidation
in a group of young males. In addition, several clinical
trials have reported the effects of tea preparations on in-
creasing energy expenditure, fat oxidation, weight loss, fat
mass, and weight maintenance after weight loss [44–47].
Bumrungpert et al. [19] revealed the garcinia reduced in-
flammation and insulin resistance in human adipocytes.
Chae et al. [48] have showed that 200 mg/kg BW
(approximately equivalent to a dose of 16.26 mg/kg/d for
humans) of Garcinia mangostana extract for significantly
decreased TC, TG, and LDL-C levels in mice. Chang et al.
[24] demonstrated that a 6-week treatment of CCGG sup-
plementation significantly reduced serum lipid content
(TC, TG, and LDL-C) and hepatic lipid content (TC and
TG). Concerning our results showed effective dose started
at CCGG-0.5X group (equivalent to 21 mg/kg/d in human).
Therefore, compared to previous studies focusing on single
ingredient, the CCGG might have the synergic beneficial
effects with relatively lower dose consumption.
Conclusion
We demonstrated hypolipidemic effects of a 6-weeks
dietary supplementation using a combined extract
(consisting of CCGG) in HED-fed SD rats. CCGG mark-
edly attenuated serum and hepatic lipid profiles with
dose-dependent effects, and increased HDL-C. It is there-
fore suggested that CCGG may represent a new type of
hypolipidemic agents and they may have a potent effects
of ameliorating hyperlipidemia, insulin resistance, liver
steatosis, and related inflammation.
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